Navigation Links
Maker of VSL#3 probiotic offers assistance program for ulcerative colitis and ileal pouch patients
Date:1/31/2012

GAITHERSBURG, MD, January 31 People who have Ulcerative Colitis (UC) or Ileal Pouch know that finding the right regimen for extending their time between flares is crucial to successfully living with the condition. The solution is often a personalized combination of drugs, dietary changes and, for many, the addition of VSL#3, a probiotic medical food designated for the dietary management of these conditions. Now, Sigma-Tau Pharmaceuticals, Inc., maker of VSL#3 medical food is sponsoring a Patient Assistance Program (PAP) to help in-need patients obtain its prescription-only double strength formulation VSL#3 DS.

The VSL#3 DS Patient Assistance Program is one of the first to provide assistance for a probiotic preparation. Sigma-Tau created this program in reaction to patient response to the product.

"We hear from many patients that VSL#3 DS is integral in the routine they adhere to in order to manage their diets," said Mary Berry, senior product manager at Sigma-Tau. "While this product is covered as a Tier 3 co-pay in many prescription plans, there are still many patients who do not have coverage and cannot afford to keep using it. We want to change that and make sure people who depend on VSL#3 DS can obtain it."

VSL#3 stands apart from other probiotics since it is not a supplement it is a refrigerated medical food. It is one of the few probiotic preparations supported by Level 1 (double-blind, placebo-controlled) scientific data, and has been the subject of a collection of more than 80 studies that have demonstrated its application in the dietary management of IBS, Ulcerative Colitis, and Ileal Pouch.

VSL#3 DS delivers 900 billion bacteria per packet (up to 22.5 times more potent than the average probiotic) and consists of 8 strains of live, freeze-dried lactic acid bacteria. It is the only probiotic recognized as an effective tool in the dietary management of ileal pouch by the American College of Gastroenterology1 and by the Cochrane Review2.

The VSL#3 DS PAP varies with each patient depending on individual evaluation. The eligibility criteria for this program is that the patient must have an applicable diagnosis or physician referral, be a legal U.S. resident, and must meet a financial need criteria.

Decisions for coverage are usually announced within two business days after applying. The product is shipped directly to the patient, and one can reapply for assistance every November to ensure continued supply of the probiotic.


'/>"/>
Contact: Nicole Egan
negan@rlapr.com
914-241-0086
Robin Leedy & Associates, Inc.
Source:Eurekalert

Related biology news :

1. A new species of gall makers in the aphid genus of plant lice was found in China
2. Sea squirt pacemaker gives new insight into evolution of the human heart
3. What motivates environmental activists, policymakers? asks new research center
4. Filmmakers Joel and Ethan Coen among 2011 Dan David Prize winners
5. Brupbacher Prize goes to B. Vogelstein and J. Hoeijmakers for research on colorectal and skin cancer
6. Ocean fertilization summary for policymakers published
7. Oil spill symposium to convene scientists, media, policymakers and community leaders
8. Global Rainmakers Appoints James M. Demitrieus as Chief Operating Officer
9. Global Rainmakers Appoints James M. Demitrieus as Chief Operating Officer
10. New technology may prolong the life of implanted devices, from pacemakers to chemotherapy ports
11. Global Rainmakers Delivers World Class Iris Capability for Portoss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the ... at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application ... team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
(Date:6/23/2016)... 22, 2016  Amgen (NASDAQ: AMGN ) ... QB3@953 life sciences incubator to accelerate the development ... laboratory space at QB3@953 was created to help high-potential ... for many early stage organizations - access to laboratory ... Amgen launched two "Amgen Golden Ticket" awards, providing each ...
Breaking Biology Technology: